← Back to guidelines
Allergy & Immunology4 papers

Neoplasm of duodenal submucosa

Last edited: 4/15/2026

Overview

Neoplasms of the duodenal submucosa encompass both benign adenomas and malignant carcinomas, including intestinal-type and anaplastic carcinomas, often diagnosed via endoscopic biopsy. 1

Diagnosis

  • Endoscopic biopsy is crucial for initial diagnosis, accurately identifying 85% of cases when compared to resection specimens. 1
  • Immunohistochemical staining, particularly for carcinoembryonic antigen (CEA), can aid in distinguishing between benign and malignant lesions. 1
  • Endoscopic appearance often differentiates benign neoplasms as polyps or plaques, while malignant lesions may mimic colonic or gastric carcinomas endoscopically. 1
  • Management

  • Surgical resection is the primary treatment for malignant neoplasms, indicated for both suspected and confirmed malignancies based on biopsy findings. 1
  • Further histopathological examination post-resection is essential for confirming initial biopsy diagnoses, especially in discordant cases. 1
  • No specific drug treatments are detailed in the provided abstracts; management focuses on surgical intervention and pathological confirmation. 1
  • Special Populations

  • No specific guidance provided for pregnancy, pediatrics, elderly, or comorbidities in the given abstracts. 1
  • Key Recommendations

  • Utilize endoscopic biopsy for initial diagnosis of duodenal submucosal neoplasms, with high confidence in accuracy for most cases. (Evidence: Moderate) 1
  • Incorporate immunohistochemical markers, such as CEA, to enhance diagnostic precision between benign and malignant lesions. (Evidence: Moderate) 1
  • Confirm initial biopsy diagnoses through surgical resection and histopathological examination, especially in cases where malignancy is suspected but not definitively confirmed. (Evidence: Moderate) 1
  • References

    1 Blackman E, Nash SV. Diagnosis of duodenal and ampullary epithelial neoplasms by endoscopic biopsy: a clinicopathologic and immunohistochemical study. Human pathology 1985. link80129-5)

    Original source

    1. [1]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG